drugset / Trial / NCT07110051

Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

NCT07110051

Recruiting 128 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindPrevention

Summary

In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.

Timeline

Start
2025-01-15
Primary completion
2025-09-15
Completion
2025-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nalbuphine Small molecule 0.2 mg/kg
Comparator Tramadol Other / unclassified 2 mg/kg